Accendra Health Q1 revenue falls, misses estimates

Accendra Health

11/05/2026 11:38

Overview

U.S. home-based care provider's Q1 revenue declined and missed analyst expectations

Adjusted EPS and adjusted EBITDA for Q1 both beat analyst expectations

Company announced $1.5 bln balance sheet optimization transaction to reduce leverage and extend maturities

Outlook

Accendra Health affirms prior full-year 2026 guidance for net revenue and adjusted EBITDA

Company plans to complete balance sheet optimization transaction in the near term

Outlook assumes stable market conditions, consumer demand, supply chain, and interest rates

Result Drivers

BUSINESS TRANSFORMATION - Co said results were aligned with expectations as it continues transformation into a pure play home-based care company

DIVESTITURE TRANSITION - Transition services and separation activity related to the divestiture of Owens & Minor are on track, per CEO Edward Pesicka

Company press release: ID:nBw4lvDcda

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Miss
$627.80 mln
$644.64 mln (6 Analysts)
Q1 Adjusted EPS
Beat
-$0.04
-$0.10 (6 Analysts)
Q1 Net Income
-$6.47 mln
Q1 Adjusted EBITDA
Beat
$58.40 mln
$57.68 mln (6 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and 2 "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

Wall Street's median 12-month price target for Accendra Health Inc is $3.00, about 16.2% below its May 8 closing price of $3.58

The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 2 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)